SS Innovations International Files Its Response To Request Additional Information Letter With FDA For Its Submission Of SSi Mantra Surgical Robotic System
SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible
Share
Why It Matters
SS Innovations sent the FDA the extra information it asked for about their surgical robot. This is a normal step that shows they are moving forward with their approval process.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.